Prilenia Archieves Last Patient Visit in Phase 3 PROOF-HD Clinical Study for Huntington's Diseasekatie8288Mar 28, 20230 min read
Community Update: Novartis development of Votoplam in HD: INVEST-HD Phase 3 trial information now available
Sarepta Therapeutics Announces Submission of Clinical Trial Application for SRP-1005, its Investigational Treatment for Huntington’s Disease
Comments